KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bath & Body Works (BBWI) Cash & Equivalents (2016 - 2026)

Bath & Body Works (BBWI) has disclosed Cash & Equivalents for 18 consecutive years, with $953.0 million as the latest value for Q1 2026.

  • Quarterly Cash & Equivalents rose 41.39% to $953.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $953.0 million through Jan 2026, up 41.39% year-over-year, with the annual reading at $953.0 million for FY2026, 41.39% up from the prior year.
  • Cash & Equivalents for Q1 2026 was $953.0 million at Bath & Body Works, up from $236.0 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $2.0 billion in Q1 2022, with the low at $191.0 million in Q4 2024.
  • Average Cash & Equivalents over 5 years is $727.3 million, with a median of $651.0 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents tumbled 79.53% in 2022, then skyrocketed 74.78% in 2023.
  • Over 5 years, Cash & Equivalents stood at $295.0 million in 2022, then surged by 39.66% to $412.0 million in 2023, then crashed by 53.64% to $191.0 million in 2024, then grew by 23.56% to $236.0 million in 2025, then soared by 303.81% to $953.0 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $953.0 million, $236.0 million, and $364.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.